Dr Tuba Gide

 |  TubaGide

Dr Tuba Gide is a post-doctoral researcher at Melanoma Institute Australia, The University of Sydney. She completed her PhD in 2019, focusing on the identification of biomarkers of response and resistance to anti-PD-1 based immunotherapies in metastatic melanoma. Her current research focuses on integrating cutting-edge technologies to identify the patients who will benefit from the standard-of-care immunotherapies and the patients who require treatment with novel drug combinations, ultimately enabling more accurate patient stratification into personalised treatments and improving patients' outcomes.